BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen P, Shi X, He W, Zhong G, Tang Y, Wang H, Zhang P. mRNA vaccine-a desirable therapeutic strategy for surmounting COVID-19 pandemic. Hum Vaccin Immunother 2022;18:2040330. [PMID: 35321627 DOI: 10.1080/21645515.2022.2040330] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Mihaylova A, Lesichkova S, Baleva M, Nikolova-Vlahova M, Kundurzhiev T, Kolevski A, Naumova E. Durability of humoral and cell-mediated immune response after SARS-CoV-2 mRNA vaccine administration. J Med Virol 2023;95:e28360. [PMID: 36448089 DOI: 10.1002/jmv.28360] [Reference Citation Analysis]
2 Issa SS, Sokornova SV, Zhidkin RR, Matveeva TV. The Main Protease of SARS-CoV-2 as a Target for Phytochemicals against Coronavirus. Plants 2022;11:1862. [DOI: 10.3390/plants11141862] [Reference Citation Analysis]